Epidermal Growth Factor Receptor Mutations in Plasma DNA Samples Predict Tumor Response in Chinese Patients With Stages IIIB to IV Non–Small-Cell Lung Cancer
作者： Hua Bai , Li Mao , Hang Shu Wang , Jun Zhao , Lu Yang
关键词: Carcinoma 、 Cancer research 、 Biomarker (medicine) 、 Epidermal growth factor receptor 、 Medicine 、 Lung cancer 、 Cancer 、 Tyrosine kinase 、 Mutation 、 Gefitinib 、 Pathology 、 Oncology
摘要: Purpose Mutations in the epidermal growth factor receptor (EGFR) kinase domain can predict tumor response to tyrosine kinase inhibitors (TKIs) in non–small-cell lung cancer (NSCLC). …
sci-hub.se 参考文章(25)
W.K. (Bill) Evans, Gefitinib does not improve survival when combined with paclitaxel and carboplatin chemotherapy in people with advanced non-small-cell lung cancer Cancer Treatment Reviews. ,vol. 30, pp. 655- 659 ,(2004) , 10.1016/J.CTRV.2004.08.002
Donald Maxwell Parkin, Ling Yang, Yude Chen, Liandi Li, Mortality time trends and the incidence and mortality estimation and projection for lung cancer in China Chinese journal of lung cancer. ,vol. 8, pp. 274- 278 ,(2005) , 10.3779/J.ISSN.1009-3419.2005.04.05
Manel Esteller, David Sidransky, Montserrat Sanchez-Cespedes, Stephen B. Baylin, Rafael Rosell, James G. Herman, Detection of Aberrant Promoter Hypermethylation of Tumor Suppressor Genes in Serum DNA from Non-Small Cell Lung Cancer Patients Cancer Research. ,vol. 59, pp. 67- 70 ,(1999)
Tan Min Chin, Diyanah Anuar, Ross Soo, Manuel Salto-Tellez, Wei Qi Li, Baidah Ahmad, Soo Chin Lee, Boon Cher Goh, Kazuyuki Kawakami, Amanda Segal, Barry Iacopetta, Richie Soong, Detection of epidermal growth factor receptor variations by partially denaturing HPLC Clinical Chemistry. ,vol. 53, pp. 62- 70 ,(2007) , 10.1373/CLINCHEM.2006.074831
Wilbur A Franklin, Robert Veve, Fred R Hirsch, Barbara A Helfrich, Paul A Bunn, Epidermal growth factor receptor family in lung cancer and premalignancy. Seminars in Oncology. ,vol. 29, pp. 3- 14 ,(2002) , 10.1053/SONC.2002.31520
Thomas J. Lynch, Daphne W. Bell, Raffaella Sordella, Sarada Gurubhagavatula, Ross A. Okimoto, Brian W. Brannigan, Patricia L. Harris, Sara M. Haserlat, Jeffrey G. Supko, Frank G. Haluska, David N. Louis, David C. Christiani, Jeff Settleman, Daniel A. Haber, Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib The New England Journal of Medicine. ,vol. 350, pp. 2129- 2139 ,(2004) , 10.1056/NEJMOA040938
Daniel B. Costa, Susumu Kobayashi, Daniel G. Tenen, Mark S. Huberman, Pooled analysis of the prospective trials of gefitinib monotherapy for EGFR-mutant non-small cell lung cancers. Lung Cancer. ,vol. 58, pp. 95- 103 ,(2007) , 10.1016/J.LUNGCAN.2007.05.017
H Kimura, M Suminoe, K Kasahara, T Sone, T Araya, S Tamori, F Koizumi, K Nishio, K Miyamoto, M Fujimura, S Nakao, Evaluation of epidermal growth factor receptor mutation status in serum DNA as a predictor of response to gefitinib (IRESSA) British Journal of Cancer. ,vol. 97, pp. 778- 784 ,(2007) , 10.1038/SJ.BJC.6603949
Victor Cohen, Jason S. Agulnik, Jonathan Jarry, Gerald Batist, David Small, Harvey Kreisman, Neely Adriana Tejada, Wilson H. Miller, George Chong, Evaluation of denaturing high-performance liquid chromatography as a rapid detection method for identification of epidermal growth factor receptor mutations in nonsmall-cell lung cancer Cancer. ,vol. 107, pp. 2858- 2865 ,(2006) , 10.1002/CNCR.22331
N. BRUHN, T. BEINERT, C. OEHM, B. JANDRIG, I. PETERSEN, X. Q. CHEN, K. POSSINGER, M. FLEISCHHACKER, Detection of Microsatellite Alterations in the DNA Isolated from Tumor Cells and from Plasma DNA of Patients with Lung Cancer Annals of the New York Academy of Sciences. ,vol. 906, pp. 72- 82 ,(2006) , 10.1111/J.1749-6632.2000.TB06594.X